<DOC>
	<DOCNO>NCT00044720</DOCNO>
	<brief_summary>The incidence efficacy failure 12 month two regimen .</brief_summary>
	<brief_title>Study Evaluating Sirolimus End Stage Renal Disease High Risk Kidney Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Graft v Host Disease</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>Inclusion Criteria Age : 13 year old , 40 kg Endstage renal disease AfricanAmerican/Black transplant recipient and/or repeat renal transplant recipient lose previous allograft Exclusion Criteria Evidence active infection Evidence abnormal chest xray Patients HIV .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Kidney Transplant</keyword>
</DOC>